Actinium Pharmaceuticals (ATNM) Return on Equity [ROE] (2011 - 2026)
Actinium Pharmaceuticals (ATNM) recorded Return on Equity [ROE] of 69.36% in Q2 2026, up 252.94 percentage points from -183.58% a year earlier and up 532.39 percentage points from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Actinium Pharmaceuticals reported Return on Equity [ROE] of -166.96%, down 56.33 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four straight years, with a five-year change of -100.61 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -110.63% in FY2024 (-15.71 pp), -94.92% in FY2023 (-46.21 pp), -48.71% in FY2022 (-11.97 pp) and -36.74% in FY2021 (+29.61 pp).
- The Q2 2026 figure is the highest quarterly Return on Equity [ROE] in data going back to Q4 2011.
- On a year-over-year basis, Return on Equity [ROE] rose in three of the last eight quarters, with an average year-over-year change of -59.44 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 252.94 percentage points in Q2 2026, against a drop of 307.31 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -463.03% (Q1 2026), -313.51% (Q4 2025) and -210.99% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Actinium Pharmaceuticals | 36.16 Mn | 36.16 Mn | - | 69.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.36% |
| Mar 31, 2026 | -463.03% |
| Dec 31, 2025 | -313.51% |
| Sep 30, 2025 | -210.99% |
| Jun 30, 2025 | -183.58% |
| Mar 31, 2025 | -155.72% |
| Dec 31, 2024 | -107.78% |
| Sep 30, 2024 | -99.74% |
| Jun 30, 2024 | -97.21% |
| Mar 31, 2024 | -115.79% |
| Dec 31, 2023 | -123.47% |
| Sep 30, 2023 | -106.21% |
| Jun 30, 2023 | -86.78% |
| Mar 31, 2023 | -65.53% |
| Dec 31, 2022 | -49.47% |
| Sep 30, 2022 | -41.21% |
| Jun 30, 2022 | -37.29% |
| Mar 31, 2022 | -34.61% |
| Dec 31, 2021 | -32.28% |
| Sep 30, 2021 | -28.86% |
API Access
Actinium Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();